DCB Bank Ltd
DCBBANKDCB Bank Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.
The sharpest disagreement: the price moved +50.4% in a year while annual EPS moved +16.1% — the difference is re-rating, and re-rating has to be repaid with earnings.
The price is in a confirmed uptrend (42 weeks in) while the P/BV sits at the 53rd percentile of its own 11-year range. Underneath, the last four quarters read improving — profit +35.7% year on year, and gross NPA has eased to 2.43%. What settles it: whether earnings grow into a price that has already moved.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
DCB Bank Ltd trades at ₹182, in a confirmed uptrend and 42 weeks into that stage. That is +3.3% against its own 200-day average. It sits at 80% of a 52-week range of ₹129 to ₹195. On relative strength it is currently behind the NIFTY 500 on a trailing-13-week view (1 week and counting).
Today the stock is in a confirmed uptrend — week 42 of stage 2, confirmed. At ₹182 it trades +3.3% versus its 200-day average and sits at 80% of its 52-week range (₹129–₹195).
Against the market, two honest reads. Cumulative: over the last 10.5 years the stock moved +160% while the NIFTY 500 moved +284% — behind the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (1 week and counting; last ahead the week of 2026-08-07) — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Story check
DCB Bank Ltd's story is not scored yet against the markers our research file set on 17 May 2026. Where it sits in its own cycle: EARLY_EXPANSION. Our fortnightly research layers last read it on 19 July 2026.
What is proven. See the research file
What is not proven yet. After explicitly ruling out capital raise through FY27 in Oct 2025 and Jan 2026, management announced ₹1,100-1,500 Cr raise planned Q2/Q3 FY27 — a documented consistency failure with ~10% dilution at current price.
Layer 1 read, 19 July 2026 — KEEP. Profitable private bank at 0.94x book with GNPA at a 7-year low and price not yet run — the depressed-breakout sweet spot.
What would change Layer 1’s mind. GNPA re-accelerating above ~3.3% or credit cost breaking above 55bps (reversing the asset-quality trend), or the ROE guidance slipping below ~11% — that would turn the below-book multiple from a setup into the trap.
Layer 2 read, 19 July 2026 — ADVANCE. Cheapest clean lender in the batch — below-book bank with GNPA at a 7-year trough riding a BFSI risk-on wave. DCB trades at 0.9x book (P/BV 47.5th percentile) with GNPA falling to a 7-year trough and credit cost BEATING its own guide (FY26 40bps, Q4 30-33bps), so the cheap book is a clean compounding book, not a masked blow-up. External streams reinforce it: the sector is earnings-led de-rating with asset quality at decadal-best and foreign money is rotating BFSI-first. The capital-raise guidance MISS is a growth-funding pace event, not a thesis break.
What would change Layer 2’s mind. A credit-cost surge or fresh slippage turning the improving GNPA trajectory dirty (the sector_falsification: ECL top-of-range + fresh slippage), OR the announced capital raise being priced at a deep discount to book that dilutes the 0.9x thesis rather than funding accretive growth.
Layer 3 read, 19 July 2026 — DEPLOY. Cheap lender at 0.9x book with 7-yr-best asset quality; promoter infusion just CLEARED, refuting the conviction fear. DCB trades at PE 8.36 (40th pct) and below book with GNPA at a 7-year trough and a credit-cost guidance BEAT, and the RBI-pending promoter infusion actually landed — stake rose 14.73%->16.23%, directly mitigating the R5 'promoter could fall below 14%' risk. The one real management caveat is the capital-raise reversal (Oct-2025 'no raise' -> Apr-2026 Rs1,100-1,500 Cr raise), but it is growth-driven with Tier 1 still healthy at 14.85% and track record STRONG (3 record PATs). Remaining risks are macro/rate-conditional, none HIGH.
The test written in advance. Capital Raise Reversal — Management Credibility and Dilution — Capital Raise Reversal — Management Credibility and Dilution Capital raise timing announcement and pricing vs book value by the next result.
The test written in advance. West Asia Geopolitical Risk — Lower-Income Segment Exposure — West Asia Geopolitical Risk — Lower-Income Segment Exposure Slippage ratio Q1 FY27; management commentary on lower-income segment behavior by the next result.
The test written in advance. Multiple Consistency Failures Erode Management Score — Multiple Consistency Failures Erode Management Score Any new guidance that contradicts prior statements without explanation by the next result.
| Dial | Now | Was | Why it matters | Watch line |
|---|---|---|---|---|
| Asset Quality Improvement (GNPA at 7-Year… | HIGH | — | GNPA fell from 3.33% to 2.45% over 4 quarters; Net NPA 0.9% (7-year low); slippage ratio 2.3% from 3.1%; recoveries/upgrades at… | Capital raise timing announcement and pricing vs book value |
| Operating Leverage (Income +16% vs… | HIGH | — | Income growing 16% while expenses grow 11%; operating margin 25% (8-year high); cost-to-average-assets 2.5% — headcount reduced… | Capital raise timing announcement and pricing vs book value |
| Loan Growth (18-20% YoY, Secured Granular… | MEDIUM_HIGH | — | Advances +18% YoY in Q4; mortgage re-engineering to 70:30 home:business; co-lending normalized to 13.9% of book; non-co-lending… | Capital raise timing announcement and pricing vs book value |
| Fee Income Growth (Core Fee at… | MEDIUM | — | Core fee income ₹198 Cr FY26 (highest ever) +9% Q4 QoQ; fee income 1.1% of average assets vs 1% long-term target; fee is… | Capital raise timing announcement and pricing vs book value |
The dot is where the company is now; the dashed line is the level that would settle the question; a tinted band is where management says it is heading.
Lever 3 · Management change — BUILDING. GNPA fell from 3.33% to 2.45% over 4 quarters; Net NPA 0.9% (7-year low); slippage ratio 2.3% from 3.1%; recoveries/upgrades at 109% of fresh slippages in Q4. What proves it keeps working: Asset Quality Improvement (GNPA at 7-Year Lows). It stops working if Capital raise timing announcement and pricing vs book value.
Lever 8 · Demerger or value unlock — BUILDING. Income growing 16% while expenses grow 11%; operating margin 25% (8-year high); cost-to-average-assets 2.5% — headcount reduced ~800 while assets grew 18-21%. What proves it keeps working: Operating Leverage (Income +16% vs Expenses +11%). It stops working if Capital raise timing announcement and pricing vs book value.
Lever 5 · Regulatory approval — BUILDING. Advances +18% YoY in Q4; mortgage re-engineering to 70:30 home:business; co-lending normalized to 13.9% of book; non-co-lending organic growth 8.6% Q4. What proves it keeps working: Loan Growth (18-20% YoY, Secured Granular Mix). It stops working if Capital raise timing announcement and pricing vs book value.
Lever 9 · Buyback — BUILDING. Core fee income ₹198 Cr FY26 (highest ever) +9% Q4 QoQ; fee income 1.1% of average assets vs 1% long-term target; fee is liability-linked, not loan-linked. What proves it keeps working: Fee Income Growth (Core Fee at Highest-Ever Levels). It stops working if Capital raise timing announcement and pricing vs book value.
Sources: our stock research file (17 May 2026) · quarterly results through Jun 26 · the company’s own earnings calls. The story check is re-scored every results season; the record below never changes.
Revenue For a bank, revenue is everything the franchise earns — interest on the loan book plus fee and other income.
DCB Bank Ltd reported ₹1,984 Cr of income in the Jun 26 quarter, +9.4% year on year. That is the 12th straight quarter of year-on-year growth. Over 10 years it has compounded at 15.9% a year. The last full year, FY26, came in at ₹7,404 Cr. The last four reported quarters add to ₹7,575 Cr.
FY26 revenue came in at ₹7,404 Cr (+14.4% on the year), capping 10 years at 15.9% compound. The latest quarter (Jun 26) printed ₹1,984 Cr, +9.4% year on year — the 12th consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +11.7% growth against the decade's 15.9% — the current year is running slower than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +11.5% over the last 4 quarters against +16.2%/yr over the last 8 — rolling over; TTM profit +23.1% vs +20.7%/yr — stabilising.
FY26-Q4. revenue ₹1,907 Cr and profit ₹206 Cr as reported.
FY27-Q1. revenue ₹1,984 Cr and profit ₹213 Cr as reported.
Why-sources: our stock research file (17 May 2026) and the company’s own results for those quarters.
Net margin Net margin — what the bank keeps of every ₹100 of revenue after every cost, provision and tax. It is the cleanest single margin we can read for a lender.
DCB Bank Ltd's net margin is 10.7% in the Jun 26 quarter, +2.0 percentage points against the same quarter a year ago. Across 13 fiscal years the net margin has ranged 8.2% to 13.4%. The current quarter sits inside that band.
The latest quarter's net margin is 10.7%, +2.0 pp against the same quarter a year ago. Across 13 fiscal years the net margin has ranged 8.2%–13.4%.
Why: the numbers show the net margin move clearly, but the cost lines behind it sit below what we hold — so we state the move without inventing its driver.
FY26-Q4. revenue ₹1,907 Cr and profit ₹206 Cr as reported.
FY27-Q1. revenue ₹1,984 Cr and profit ₹213 Cr as reported.
Why-sources: our stock research file (17 May 2026) and the company’s own results for those quarters.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
DCB Bank Ltd earned ₹213 Cr of net profit in the Jun 26 quarter, +35.7% year on year. It is the 12th consecutive quarter of growth. Full-year FY26 profit was ₹732 Cr. The 10-year compound rate is 14.1%. That is 10.7% of the quarter's revenue. The same quarter a year earlier earned ₹157 Cr.
Jun 26 profit was ₹213 Cr, +35.7% year on year — the 12th consecutive quarter of growth. On the full year, FY26 printed ₹732 Cr (+19.0%), and the 10-year compound rate is 14.1%.
Why profit moved: revenue contributed +9.4% and the margin +2.0 pp — the quarter was margin-led: most of the profit growth came from keeping more of each sale.
Pace comparison, last four quarters: profit +23.3% vs revenue +11.7%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra rupee of revenue drops more to the bottom line.
FY26-Q4. revenue ₹1,907 Cr and profit ₹206 Cr as reported.
FY27-Q1. revenue ₹1,984 Cr and profit ₹213 Cr as reported.
Why-sources: our stock research file (17 May 2026) and the company’s own results for those quarters.
Asset quality — the ladder Gross NPA is the slice of the loan book where repayments have stopped. Net NPA is what remains after the money already set aside against those loans. Falling is healing; rising is damage arriving.
DCB Bank Ltd's gross NPA is 2.43% of the loan book in Jun 26, down from 2.98% a year ago. Net of provisions already set aside, 0.84% remains. That is the 8th straight quarter of improvement. Across the 12 quarters held here the book has ranged 2.43% to 3.43%.
Jun 26: gross NPA at 2.43% and net NPA at 0.84%, against 2.98% / 1.22% a year ago. Over the 12 quarters we hold, the book's worst reading was 3.43% and its best is 2.43% — which is the current print. The ladder has now improved for 8 consecutive quarters.
The synthesis: profit growth at a bank is only as good as the book behind it, and this book is healing on a multi-quarter streak. A note on depth: quarterly provisioning detail is not in our numbers yet, so this ladder reads levels and trend, not the cost of the cleanup.
Why the ladder moved: recoveries, write-offs and slippages each play a part, and that split sits below what we hold — the numbers show the healing; the driver mix does not travel with them.
The loan book We read the loan book through revenue — when the book grows, revenue grows with it. It is a rough proxy, and we say so: rate moves and fee swings can shift it a few points in any one year.
DCB Bank Ltd's revenue grew +14.4% in FY26 to ₹7,404 Cr, so the book is growing. The latest quarter ran +9.4% year on year. The net margin on that income is 10.7%, +2.0 percentage points against a year ago. Interest income is a proxy for the book; rate moves can shift it a few points in any one year.
FY26 revenue was ₹7,404 Cr, +14.4% on the year, and the latest quarter ran +9.4% year on year. The net margin on that revenue is 10.7% this quarter (+2.0 pp YoY) — growth with a widening margin on it.
The synthesis: a lender compounds when the book grows while the margin holds and the loan book stays clean — gross NPA is the loan-quality read we carry here.
Returns on equity and assets Two numbers rate a bank: ROE — what it earns on shareholder money — and ROA — what it earns on everything it deploys. ROE above ~13–15% earns its keep; below that, growth builds book slowly.
DCB Bank Ltd earns a return on equity of 12% in FY26. Its trough over the ladder below was 7% in FY22. For a lender the balance sheet is the operating asset, so equity return and asset return have to be read together.
FY26 ROE came in at 12%, recovered from a FY22 trough of 7%. Return on assets is withheld on this page — its two source series disagree for this quarter. That return is below the bar a bank must clear to compound book value quickly — which is also the honest reason the stock trades where it does.
Why ROE moved: profit compounded 14.1% a year over 10 years while the equity base grew more slowly — earnings recovering faster than book value builds is what lifts ROE off a trough.
Debt
For a bank, borrowings are raw material, not a warning sign — solvency is read through the returns and the loan book. A manufacturer’s debt is a claim against its profits, so the debt-to-equity lens that works everywhere else misleads on a lender and is not applied here.
A manufacturer’s debt is a claim against its profits; a bank’s borrowings are its inventory — money taken in to be lent out. The debt lens that works everywhere else misleads here, so this page does not apply it. The solvency questions for a bank — is the loan book sound, is the equity earning — are read through the loan-book and returns sections above.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
Domestic institutions added 4.7 points of DCB Bank Ltd over 8 quarters, the biggest move on the register. That takes domestic institutions to 32.3% of the company. Promoters moved +1.5 points over the same window, to 16.2%. The register is read on the four disclosed classes only; nothing is inferred between filings.
Why this happened. The core driver of DCB's PAT re-rating. Each quarter of lower credit costs drops straight to the bottom line. Credit cost ran at 40 bps in FY26 vs 45 bps guidance — management's through-cycle model is 45-55 bps, and the bank is running at 30-33 bps. This gives meaningful PAT leverage if asset quality holds. The upgrade/recovery ratio at 109% of slippages in Q4 FY26 is the strongest indication that the improvement is durable, not a provisioning artifact.
The register over the last two years — Domestic institutions: +4.7 points over 8 quarters to 32.3%; Promoters: +1.5 points over 8 quarters to 16.2%; Foreign institutions: −1.2 points over 8 quarters to 13.5%. Note the structure: promoters hold under 20% — this is a widely-held company where institutions, not a family, set the direction.
Why the register moved: domestic institutions drove it (+4.7 points), alongside promoters (+1.5 points) — steady accumulation by institutions reading the same numbers this page reads.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
DCB Bank Ltd: the Z-score is omitted — it was built for manufacturers, not banks, and applying it here would be theatre. The Z-score was built for manufacturers and is not applied to banks and lenders, so solvency here is read from the capital and asset-quality lines instead.
Why this happened. DCB is growing at 18-20% through a deliberate mix optimization: shifting mortgages from DSA-sourced (2.5Y avg tenure) to self-sourced (6+ year tenure), moving business loans to >60% of incremental mortgage sourcing, and targeting SME book expansion. Advances mix is becoming more secured, granular, and higher-yielding. The Mid-SME strategy (₹3-10 Cr tickets) is in build-out phase with a 3-4 quarter horizon for material contribution.
The safety line in one sentence: the Z-score is omitted — it was built for manufacturers, not banks, and applying it here would be theatre.
Valuation For a bank we price the book, not the earnings: P/BV is what the market pays for each ₹1 of the bank's net worth. A bank below 1× book is priced below the value of what it owns, net of what it owes.
DCB Bank Ltd trades at 0.9× P/BV, mid-range by its own standards (53rd percentile). Its long-run median P/BV is 0.9×, measured across 10.5 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Why this happened. The operating leverage demonstrates a genuine productivity step-change. Headcount reduced from ~11,339 to ~10,981 while achieving 18-20% balance sheet growth — driven by digitalization and AI deployment. Cost-to-income at 61.84% in Q3 and improving. The pre-COVID branch expansion is now fully productive. Going forward, incremental branch adds (targeting 500 branches) and headcount builds to 13,000 by FY27-end will test whether the leverage ratio holds.
Today's P/BV of 0.9× is mid-range by its own standards (53rd percentile), against a long-run median of 0.9× measured over 10.5 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
The honest context for that discount: a bank earning about 12% on its equity is worth less per rupee of book, and the market has priced that in rather than overlooked it. The discount closes only if the returns themselves improve.
🚨 Why the multiple sits where it does: over the past year book value grew while the price moved +50.4% — price and book moved together, holding the multiple in its range.
The price move, decomposed: over 5y, of the +14.6%/yr price move, ~+12.0%/yr came from book-value growth and ~+2.6 pp from the multiple (expanding); over 10y, of the +4.8%/yr price move, ~+12.4%/yr came from book-value growth and ~−7.6 pp from the multiple (compressing). The split is the honest approximate (price return minus book-value growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is unremarkable against its own past, so the story rests on the book-value line underneath it, not the multiple.
Stage: Mixed Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
DCB Bank Ltd reads as mixed on its fundamental arc. Mixed — the growth curves are steadily positive, but ROE at 11.2% is below the 12% bar this page requires to call it Consistent. The read is built from 12 quarters across 4 curves, on full evidence.
Why it matters: when the curves disagree, the per-curve reads above matter more than any single verdict.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +14.4% | +20.8% | +16.4% | +15.9% |
| Profit | +19.0% | +16.2% | +16.9% | +14.1% |
| EPS | +16.1% | +15.0% | +16.0% | +12.8% |
| Share price | +50.4% | +16.5% | +14.6% | +4.8% |
4-Factor Sector Score
57.0/100 — rank 7 of 18 in Banks - Private · 100% evidence confidence
DCB Bank Ltd scores 57.0 out of 100 against the 18 companies it is compared with in Banks - Private, ranking 7. Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -7.2% and the one-year return is 43.2%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth.
The four contributions add to the total exactly: 22.8 + 11.4 + 17.4 + 5.4 = 57. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if ROA rolls over or gross NPA rises while sector-relative strength deteriorates.
Said versus delivered
What DCB Bank Ltd's management promised, set against what actually arrived — 3 tracked promises on the record. Read straight from the company’s own earnings calls. A promise that slipped stays on this page after it is met.
Capital Raise Plans Reversal · 24 April 2026. In the Oct 2025 call, management explicitly ruled out any capital raise for the remainder of FY26 and the following year (FY27), supported by a Tier 1 capital ratio of 14.85%. As recently as Jan 2026, management reiterated there was 'no urgency for capital.' However, the Apr 2026 call reveals an active fundraising plan of ₹1,100–1,500 crores now targeted for Q2/Q3 FY27 — squarely within the period management had publicly excluded from capital requirements — with no substantive explanation for the reversal beyond broad growth needs that were equally evident in prior calls. Later call (Apr 2026): “Regarding fundraising, we should be looking at it in the next two quarters, either late Q2 or early Q3. We see the bank continuing to grow at this pace and we will hit our internal red flags for capital by Q1 FY28. We don”.
🚨 Slippage Target Recategorized to Ambition · 17 October 2025. In the July 2025 call, management stated the portfolio health goal was to get the non-gold slippage ratio down to a 2.5 kind of level, forecasting that microfinance pain would continue for 'two, three quarters.' Yet, in the October 2025 call, when discussing similar metrics, management explicitly stated, 'That's not a guidance. That is an ambition,' effectively removing the prior quantitative directional commitment to the market.
Capital Raising Needs Deferred · 17 October 2025. Management previously framed external capital raising as imminent—either from the market when valuation allowed (April 2025) or from the promoter, with the latter expected to conclude before the October 2025 call (July 2025). Contrarily, in the October 2025 call, management reversed course, stating definitively: 'For the rest of this year and the next year, I don't see a reason why we need to raise capital,' suggesting a lack of near-term requirement despite high growth rate ambitions.
Every quote above is taken word for word from the company’s own earnings calls.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Tamilnad Mercantile Bank LtdTMB | 77.3/100Favorable setup100% evidence | LEADER | 23.3/35 Income 12.9% · PAT 20.5% 100% evidence | 22.6/25 ROA 2% · ROE 14% · GNPA 0.7% 100% evidence | 12.7/20 P/BV 1.27× · P/BV÷ROE 0.09 100% evidence | 18.7/20 RS sector 22.7% · RS bench 36.5% · 1Y 97.8%11 of 12 weeks ahead 100% evidence |
| Exact sum: 23.3 + 22.6 + 12.7 + 18.7 = 77.3 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 2Karur Vysya Bank LtdKARURVYSYA | 71.2/100Favorable setup100% evidence | BREAKING OUT | 27.2/35 Income 16% · PAT 37% 100% evidence | 22.9/25 ROA 1.8% · ROE 19.1% · GNPA 0.7% 100% evidence | 7.7/20 P/BV 2.27× · P/BV÷ROE 0.12 100% evidence | 13.4/20 RS sector 5.8% · RS bench 18.7% · 1Y 51.4%6 of 12 weeks ahead 100% evidence |
| Exact sum: 27.2 + 22.9 + 7.7 + 13.4 = 71.2 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 3South Indian Bank LtdSOUTHBANK | 62.2/100Mixed-positive evidence90% evidence | LEADER | 21.7/35 Income 6.9% · PAT 13.5% 95% evidence | 13.4/25 ROA 1.2% · ROE 13.5% · GNPA — 68% evidence | 14.6/20 P/BV 1.01× · P/BV÷ROE 0.07 100% evidence | 12.5/20 RS sector 1.8% · RS bench 14.2% · 1Y 56.6%10 of 12 weeks ahead 100% evidence |
| Exact sum: 21.7 + 13.4 + 14.6 + 12.5 = 62.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4Karnataka Bank LtdKTKBANK | 61.7/100Mixed-positive evidence100% evidence | LEADER | 16.5/35 Income 0.5% · PAT 23.4% 100% evidence | 10.7/25 ROA 1% · ROE 10.4% · GNPA 2.6% 100% evidence | 14.5/20 P/BV 0.89× · P/BV÷ROE 0.09 100% evidence | 20.0/20 RS sector 22.7% · RS bench 37.1% · 1Y 79.9%10 of 12 weeks ahead 100% evidence |
| Exact sum: 16.5 + 10.7 + 14.5 + 20 = 61.7 · Decision use: Price leads the evidence: RS versus the benchmark is 37.1%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 5City Union Bank LtdCUB | 61.0/100Mixed-positive evidence100% evidence | TURNING | 24.7/35 Income 19.8% · PAT 20.5% 100% evidence | 16.6/25 ROA 1.4% · ROE 13.2% · GNPA 1.7% 100% evidence | 10.8/20 P/BV 1.95× · P/BV÷ROE 0.15 100% evidence | 8.9/20 RS sector -6.2% · RS bench 5.7% · 1Y 32.4%6 of 12 weeks ahead 100% evidence |
| Exact sum: 24.7 + 16.6 + 10.8 + 8.9 = 61 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6Jammu and Kashmir Bank LtdJ&KBANK | 60.0/100Mixed-positive evidence88% evidence | LEADER | 12.8/35 Income 4.8% · PAT 7.2% 86% evidence | 16.2/25 ROA 1.3% · ROE 15.4% · GNPA — 72% evidence | 14.3/20 P/BV 1.01× · P/BV÷ROE 0.07 100% evidence | 16.7/20 RS sector 11.3% · RS bench 24.3% · 1Y 52.1%12 of 12 weeks ahead 100% evidence |
| Exact sum: 12.8 + 16.2 + 14.3 + 16.7 = 60 · Decision use: Price leads the evidence: RS versus the benchmark is 24.3%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 7DCB Bank Ltdthis pageDCBBANK | 57.0/100Mixed-positive evidence100% evidence | ASLEEP | 22.8/35 Income 11.5% · PAT 23.1% 100% evidence | 11.4/25 ROA 0.8% · ROE 12% · GNPA 2.4% 100% evidence | 17.4/20 P/BV 0.9× · P/BV÷ROE 0.07 100% evidence | 5.4/20 RS sector -7.2% · RS bench 4.3% · 1Y 43.2%1 of 12 weeks ahead 100% evidence |
| Exact sum: 22.8 + 11.4 + 17.4 + 5.4 = 57 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -7.2% and the one-year return is 43.2%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 8Dhanlaxmi Bank LtdDHANBANK | 52.9/100Mixed-positive evidence97% evidence | FADING | 25.8/35 Income 21.7% · PAT 32.2% 95% evidence | 8.0/25 ROA 0.5% · ROE 7.2% · GNPA 1.8% 95% evidence | 7.9/20 P/BV 0.84× · P/BV÷ROE 0.12 100% evidence | 11.2/20 RS sector 2.5% · RS bench 15.3% · 1Y 22.3%9 of 12 weeks ahead 100% evidence |
| Exact sum: 25.8 + 8 + 7.9 + 11.2 = 52.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 9Federal Bank LtdFEDERALBNK | 52.7/100Mixed-positive evidence75% evidence | BREAKING OUT | 16.1/35 Income 6.5% · PAT 17% 76% evidence | 12.8/25 ROA — · ROE 11.6% · GNPA — 34% evidence | 5.4/20 P/BV 2.17× · P/BV÷ROE 0.19 100% evidence | 18.4/20 RS sector 13.1% · RS bench 26.3% · 1Y 78.9%10 of 12 weeks ahead 100% evidence |
| Exact sum: 16.1 + 12.8 + 5.4 + 18.4 = 52.7 · Decision use: Price leads the evidence: RS versus the benchmark is 26.3%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 10ICICI Bank LtdICICIBANK | 49.9/100Mixed-negative evidence79% evidence | BREAKING OUT | 10.6/35 Income 4% · PAT 5.7% 62% evidence | 19.9/25 ROA 2.1% · ROE 15.9% · GNPA — 68% evidence | 9.7/20 P/BV 2.69× · P/BV÷ROE 0.17 100% evidence | 9.7/20 RS sector -9.9% · RS bench 2.4% · 1Y -1.3%5 of 12 weeks ahead 100% evidence |
| Exact sum: 10.6 + 19.9 + 9.7 + 9.7 = 49.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 11RBL Bank LtdRBLBANK | 48.3/100Mixed-negative evidence88% evidence | LEADER | 23.3/35 Income 5.4% · PAT 54.8% 86% evidence | 6.6/25 ROA 0.5% · ROE 5.4% · GNPA — 72% evidence | 4.7/20 P/BV 1.42× · P/BV÷ROE 0.26 100% evidence | 13.7/20 RS sector 4.8% · RS bench 17.9% · 1Y 47.1%12 of 12 weeks ahead 100% evidence |
| Exact sum: 23.3 + 6.6 + 4.7 + 13.7 = 48.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 12Yes Bank LtdYESBANK | 47.2/100Mixed-negative evidence100% evidence | FADING | 22.6/35 Income -0.5% · PAT 37.8% 100% evidence | 12.2/25 ROA 1% · ROE 7.1% · GNPA 1.3% 100% evidence | 7.6/20 P/BV 1.36× · P/BV÷ROE 0.19 100% evidence | 4.8/20 RS sector -9.7% · RS bench 2.2% · 1Y 22.3%10 of 12 weeks ahead 100% evidence |
| Exact sum: 22.6 + 12.2 + 7.6 + 4.8 = 47.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 13HDFC Bank LtdHDFCBANK | 46.4/100Mixed-negative evidence84% evidence | ASLEEP | 13.1/35 Income 2.8% · PAT 12.5% 76% evidence | 17.2/25 ROA 1.8% · ROE 13.6% · GNPA — 68% evidence | 14.2/20 P/BV 1.86× · P/BV÷ROE 0.14 100% evidence | 1.9/20 RS sector -29.1% · RS bench -18.8% · 1Y -26.3%0 of 12 weeks ahead 100% evidence |
| Exact sum: 13.1 + 17.2 + 14.2 + 1.9 = 46.4 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 14IDFC First Bank LtdIDFCFIRSTB | 42.5/100Mixed-negative evidence82% evidence | BREAKING OUT | 26.4/35 Income 12.3% · PAT 77.3% 86% evidence | 6.0/25 ROA 0.5% · ROE 3.8% · GNPA — 72% evidence | 3.5/20 P/BV 1.52× · P/BV÷ROE 0.4 100% evidence | 6.6/20 RS sector -17.6% · RS bench 10.8% · 1Y 24%8 of 10 weeks ahead 70% evidence |
| Exact sum: 26.4 + 6 + 3.5 + 6.6 = 42.5 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -17.6% and the one-year return is 24%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 15Kotak Mahindra Bank LtdKOTAKBANK | 37.5/100Mixed-negative evidence93% evidence | ASLEEP | 8.7/35 Income 5.7% · PAT 6% 100% evidence | 16.3/25 ROA 1.9% · ROE 11.4% · GNPA — 72% evidence | 8.7/20 P/BV 2.15× · P/BV÷ROE 0.19 100% evidence | 3.8/20 RS sector -16.3% · RS bench -4.8% · 1Y 0.2%1 of 12 weeks ahead 100% evidence |
| Exact sum: 8.7 + 16.3 + 8.7 + 3.8 = 37.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 16Axis Bank LtdAXISBANK | 37.3/100Mixed-negative evidence93% evidence | ASLEEP | 6.2/35 Income 5.6% · PAT -0.2% 100% evidence | 15.2/25 ROA 1.6% · ROE 13.1% · GNPA — 72% evidence | 14.2/20 P/BV 1.71× · P/BV÷ROE 0.13 100% evidence | 1.7/20 RS sector -16% · RS bench -5.1% · 1Y 15.1%1 of 12 weeks ahead 100% evidence |
| Exact sum: 6.2 + 15.2 + 14.2 + 1.7 = 37.3 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 17IndusInd Bank LtdINDUSINDBK | 32.4/100Adverse evidence100% evidence | BREAKING OUT | 12.5/35 Income -6.4% · PAT 31.1% 100% evidence | 2.3/25 ROA 0.2% · ROE 1.4% · GNPA 3.3% 100% evidence | 3.2/20 P/BV 1.21× · P/BV÷ROE 0.89 100% evidence | 14.4/20 RS sector 2.1% · RS bench 14.9% · 1Y 30.5%7 of 12 weeks ahead 100% evidence |
| Exact sum: 12.5 + 2.3 + 3.2 + 14.4 = 32.4 · Decision use: Price leads the evidence: RS versus the benchmark is 14.9%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 18Bandhan Bank LtdBANDHANBNK | 23.3/100Adverse evidence100% evidence | FADING | 8.7/35 Income -0.2% · PAT -34% 100% evidence | 5.5/25 ROA 0.6% · ROE 4.9% · GNPA 3.1% 100% evidence | 6.3/20 P/BV 1.1× · P/BV÷ROE 0.23 100% evidence | 2.8/20 RS sector -11.2% · RS bench 0.1% · 1Y 5.7%8 of 12 weeks ahead 100% evidence |
| Exact sum: 8.7 + 5.5 + 6.3 + 2.8 = 23.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. Financial companies use P/BV÷ROE and asset quality; PEG, industrial OPM and ROCE are excluded. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is DCB Bank Ltd's share price today?
DCB Bank Ltd trades at ₹182, +50.4% over the past year. The company is valued at ₹5,864 Cr. The stock sits at 80% of its 52-week range of ₹129–₹195, +3.3% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 42 weeks in. — as of 14 August 2026.
What were DCB Bank Ltd's latest quarterly results?
DCB Bank Ltd reported total income of ₹1,984 Cr and net profit of ₹213 Cr for the Jun 26 quarter. Income rose 9.4% and profit rose 35.7% year on year. Earnings per share were ₹6.62. The net margin was 10.7%, 2.0 pp higher than a year earlier. — as of 14 August 2026.
What is DCB Bank Ltd's revenue?
DCB Bank Ltd reported revenue of ₹1,984 Cr in the Jun 26 quarter, +9.4% year on year. For the full FY26 fiscal year, revenue was ₹7,404 Cr (+14.4%). Over the last 10 years revenue compounded at 15.9% a year. — as of 14 August 2026.
What is DCB Bank Ltd's profit?
DCB Bank Ltd earned ₹213 Cr of net profit in the Jun 26 quarter, +35.7% year on year — the 12th straight quarter of growth. Full-year FY26 profit was ₹732 Cr. The net margin ran 10.7% in the latest quarter. — as of 14 August 2026.
What is DCB Bank Ltd's market cap?
DCB Bank Ltd's market capitalisation is ₹5,864 Cr at a share price of ₹182. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 14 August 2026.
What is DCB Bank Ltd's P/BV ratio?
DCB Bank Ltd trades at a P/BV of 0.9×, at the 53rd percentile of its own 11-year range, against a long-run median of 0.9×. This is a comparison with the stock's own history, not a value call — as of 14 August 2026.
Does DCB Bank Ltd pay a dividend?
Yes — DCB Bank Ltd's dividend payout was 6% of profit in FY26, and it recorded a payout in 8 of its last 13 reported fiscal years. This page holds the payout ratio, not a per-share amount. — as of 14 August 2026.
Is DCB Bank Ltd overvalued?
On its own history, DCB Bank Ltd looks mid-range: its P/BV of 0.9× sits at the 53rd percentile of its 11-year range (long-run median 0.9×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 14 August 2026.
Is DCB Bank Ltd growing?
Yes — DCB Bank Ltd is growing: latest-quarter revenue +9.4% year on year, profit +35.7%, and the net margin +2.0 pp at 10.7%. The 10-year compound rates are 15.9% (revenue) and 14.1% (profit). The earnings engine currently reads: improving — as of 14 August 2026.
How is DCB Bank Ltd performing?
DCB Bank Ltd is in a confirmed uptrend, 42 weeks in. Its latest quarter's income rose 9.4% and profit rose 35.7% year on year. Against the NIFTY 500 it has been behind on a trailing-13-week view for 1 week. This describes what the data did, not a rating. — as of 14 August 2026.
What stage is DCB Bank Ltd in?
Mixed — the growth curves are steadily positive, but ROE at 11.2% is below the 12% bar this page requires to call it Consistent. The read comes from the last 12 quarters of growth (revenue growth +11.5% latest, profit growth +23.1% latest, eps growth +20.4% latest) plus the ROE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 14 August 2026.
Is DCB Bank Ltd in an uptrend?
Yes — the price is in a confirmed uptrend (week 42 of stage 2), trading +3.3% versus its 200-day average and at 80% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 14 August 2026.
Is DCB Bank Ltd beating the market?
Not lately — on a trailing-13-week view DCB Bank Ltd is currently behind the NIFTY 500 (1 week and counting; last ahead the week of 2026-08-07), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.5 years the stock moved +160% against the NIFTY 500's +284% — behind the index over the full window. — as of 14 August 2026.
Will DCB Bank Ltd's share price go up?
This page publishes no price forecast for DCB Bank Ltd. What it measures instead: the share price is ₹182, the price is in a confirmed uptrend 42 weeks in. Its P/BV of 0.9× sits at the 53rd percentile of its own 11-year range. — as of 14 August 2026.
Who owns DCB Bank Ltd?
Promoters hold 16.2% of DCB Bank Ltd, foreign institutions 13.5%, domestic institutions 32.3% and the public 38.0% (latest quarter). The biggest move on the register over the last two years: Domestic institutions added 4.7 points over 8 quarters. — as of 14 August 2026.
Is DCB Bank Ltd's loan book healthy?
Gross NPA is 2.43% of DCB Bank Ltd's loan book, down from 2.98% a year ago — the 8th straight quarter of improvement, and net NPA stands at 0.84%. Falling NPAs are a loan book healing; rising NPAs are damage arriving — as of 14 August 2026.
Where is DCB Bank Ltd in its business cycle?
DCB Bank Ltd's FY26 net margin was 9.9%, against a 13-year band of 8.2%–13.4%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 10.7%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 14 August 2026.
What could break the DCB Bank Ltd story?
The sharpest disagreement: the price moved +50.4% in a year while annual EPS moved +16.1% — the difference is re-rating, and re-rating has to be repaid with earnings. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 14 August 2026.
Is DCB Bank Ltd a stock worth studying right now?
This is not investment advice. The machine read: DCB Bank Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: whether earnings grow into a price that has already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 14 August 2026.